Summary
CME Group Inc. (CME) filed an 8-K on March 9, 2015, announcing the successful completion of a public offering of $750 million in senior unsecured 3.000% Notes due 2025. The proceeds from this issuance are primarily earmarked for the redemption of $612.5 million of outstanding 4.40% Senior Notes due 2018, demonstrating proactive debt management by refinancing higher-cost debt with a lower coupon. The company also entered into an Underwriting Agreement with Barclays Capital Inc. and Merrill Lynch, Pierce, Fenner & Smith Incorporated, among others, to facilitate this offering. The new notes were issued under an existing indenture, as supplemented by a Seventh Supplemental Indenture. This move signals CME Group's strategy to optimize its capital structure and potentially reduce future interest expenses.
Key Highlights
- 1Completion of a $750 million public offering of 3.000% Senior Notes due 2025.
- 2Proceeds will be used to redeem $612.5 million of 4.40% Senior Notes due 2018.
- 3This transaction represents a refinancing of higher-interest debt with lower-interest debt.
- 4The offering was conducted under an existing shelf registration statement and a new Underwriting Agreement.
- 5The new notes carry an interest rate of 3.000%, payable semi-annually.
- 6The company may redeem the notes under certain conditions prior to maturity.
- 7The filing also incorporates a forward-starting interest rate swap which effectively fixed the interest payable on the new notes at an estimated annual rate of 3.11%.